CN Stock MarketDetailed Quotes
002581 Shandong Sinobioway Biomedicine
- 11.41
- +0.07+0.62%
Market Closed May 31 15:00 CST
7.53BMarket Cap-22241P/E (TTM)
11.48High11.27Low27.61KlotVolume11.30Open11.34Pre Close31.43MTurnover0.69%Turnover RatioLossP/E (Static)659.74MShares20.2852wk High3.68P/B4.57BFloat Cap8.5452wk Low12.47Limit Up400.79MShs Float71.85Historical High10.21Limit Down1.85%Amplitude4.39Historical Low--Dividend TTM11.38Avg Price12.47KlotAsk--Div YieldTTM100Lot Size14.73KlotBid
Shandong Sinobioway Biomedicine Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 22.08%101.69M | 4.85%474.02M | -2.24%323.11M | -11.95%185.82M | -10.68%83.3M | -2.69%452.08M | -5.51%330.51M | -1.05%211.05M | -1.18%93.25M | 4.89%464.6M |
| Refunds of taxes and levies | -4.61%10.52K | --0 | -99.79%11.95K | -99.80%11.03K | -98.35%11.03K | 294.82%5.82M | 222,808.63%5.74M | --5.64M | --670.2K | -15.38%1.47M |
| Net deposit increase | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in borrowings from central bank | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in placements from other financial institutions | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received from interests, fees and commissions | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in repurchase business capital | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Premiums received from original insurance contracts | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash received from reinsurance business | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in deposits from policyholders | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net increase in funds disbursed | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net cash received from trading securities | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received relating to other operating activities | -9.89%1.57M | 100.00%88.92M | 323.06%59.25M | 42.69%11.85M | -71.01%1.74M | 87.45%44.46M | -49.32%14M | -60.33%8.31M | -46.55%6.01M | -46.86%23.72M |
| Cash inflows from operating activities | 21.42%103.27M | 12.06%562.94M | 9.17%382.36M | -12.14%197.68M | -14.89%85.05M | 2.57%502.37M | -7.20%350.25M | -3.95%224.99M | -5.37%99.93M | 0.10%489.8M |
| Goods services cash paid | -64.13%3.14M | 0.31%48.81M | -62.97%17.13M | -54.15%13.95M | -45.75%8.75M | -2.93%48.66M | 129.20%46.26M | 151.85%30.43M | 145.72%16.12M | 39.90%50.13M |
| Staff behalf paid | -10.01%27.21M | -13.13%93.04M | -21.54%71.77M | -22.95%51.65M | -33.29%30.24M | -0.86%107.11M | 12.10%91.48M | 15.37%67.04M | 29.99%45.33M | 4.03%108.04M |
| All taxes paid | -47.11%5.96M | 48.99%31.75M | 113.06%25.82M | 144.21%18.08M | 133.31%11.27M | -2.17%21.31M | -41.40%12.12M | -49.24%7.41M | -24.93%4.83M | 1.06%21.78M |
| Net loan and advance increase | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net deposit in central bank and institutions | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Net lend capital | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid for fees and commissions | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid for indemnity of original insurance contract | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Policy dividend cash paid | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid relating to other operating activities | 29.17%82.16M | 12.13%425.85M | 16.93%265.77M | 24.16%171.84M | -10.20%63.61M | 6.72%379.77M | -19.24%227.3M | -28.50%138.4M | -20.50%70.83M | 14.96%355.86M |
| Cash outflows from operating activities | 4.05%118.47M | 7.65%599.45M | 0.89%380.49M | 5.04%255.53M | -16.96%113.86M | 3.93%556.85M | -6.62%377.15M | -12.60%243.27M | 0.11%137.11M | 13.81%535.81M |
| Net cash flows from operating activities | 47.23%-15.2M | 33.00%-36.51M | 106.97%1.88M | -216.40%-57.84M | 22.51%-28.81M | -18.41%-54.49M | -1.63%-26.89M | 58.55%-18.28M | -18.60%-37.18M | -348.59%-46.02M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | ---- | --28.31K | --0 | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received from returns on investments | 3,242.28%53.82M | --256.17M | --255.16M | --1.64M | --1.61M | --0 | ---- | ---- | ---- | ---- |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 4,446.30%25.05M | -80.48%4.77M | 7,443.21%3.67M | --2.65M | --551K | 149,442.32%24.45M | --48.6K | ---- | ---- | -99.96%16.35K |
| Net cash received from disposal of subsidiaries and other business units | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash received relating to other investing activities | ---- | --0 | --0 | --0 | ---- | 340.00%22M | ---- | ---- | ---- | -95.87%5M |
| Cash inflows from investing activities | 3,549.24%78.87M | 461.82%260.97M | 532,465.00%258.83M | --4.29M | --2.16M | 825.98%46.45M | --48.6K | --0 | ---- | -97.00%5.02M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -99.67%122.93K | -86.27%4.32M | -34.10%29.23M | -23.93%28.82M | 340.58%37.35M | -48.29%31.46M | 57.00%44.36M | 82.16%37.88M | -14.19%8.48M | -10.12%60.85M |
| Cash paid to acquire investments | ---- | --0 | ---- | --0 | ---- | --50M | --50M | ---- | ---- | ---- |
| Net cash paid to acquire subsidiaries and other business units | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Impawned loan net increase | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash paid relating to other investing activities | ---- | --0 | ---- | --0 | ---- | --3.4M | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -99.67%122.93K | -94.91%4.32M | -69.02%29.23M | -23.93%28.82M | 340.58%37.35M | 39.48%84.87M | 233.97%94.36M | 82.16%37.88M | -14.19%8.48M | -65.07%60.85M |
| Net cash flows from investing activities | 323.81%78.75M | 768.09%256.65M | 343.46%229.6M | 35.25%-24.53M | -315.09%-35.19M | 31.19%-38.42M | -233.80%-94.31M | -82.16%-37.88M | 14.19%-8.48M | -709.21%-55.83M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from borrowing | ---- | -93.92%13.84M | -94.54%10M | -89.78%8.23M | ---- | 4.36%227.5M | 39.89%183.25M | -38.55%80.5M | -38.55%80.5M | 37.54%218M |
| Cash received relating to other financing activities | ---- | --0 | ---- | --0 | ---- | 845.11%70.83M | ---- | ---- | ---- | 11.85%7.49M |
| Cash inflows from financing activities | ---- | -95.36%13.84M | -94.54%10M | -89.78%8.23M | --0 | 32.30%298.33M | 39.89%183.25M | -38.55%80.5M | -38.55%80.5M | 36.50%225.49M |
| Borrowing repayment | ---- | -35.81%147M | -42.59%58.27M | -69.96%18.47M | -94.35%3.47M | 21.81%229M | -25.27%101.5M | -52.68%61.5M | -35.32%61.5M | -78.52%188M |
| Dividend interest payment | -95.76%93.36K | 27.77%10.28M | -10.38%5.88M | 1.89%4M | 13.90%2.2M | 19.92%8.04M | -61.30%6.56M | -18.38%3.93M | -22.38%1.93M | -87.88%6.71M |
| -Including:Cash payments for dividends or profit to minority shareholders | ---- | --0 | ---- | --0 | ---- | --0 | ---- | --0 | ---- | ---- |
| Cash payments relating to other financing activities | ---- | 405.47%67.7M | --3.07M | --3.07M | --3.07M | -47.05%13.39M | ---- | --0 | ---- | 9.11%25.3M |
| Cash outflows from financing activities | -98.93%93.36K | -10.17%224.98M | -37.79%67.22M | -60.96%25.54M | -86.22%8.74M | 13.83%250.44M | -29.27%108.06M | -51.46%65.43M | -34.99%63.43M | -76.93%220M |
| Net cash flows from financing activities | 98.93%-93.36K | -540.86%-211.14M | -176.11%-57.22M | -214.87%-17.31M | -151.23%-8.74M | 772.07%47.89M | 445.35%75.19M | 498.00%15.07M | -48.93%17.07M | 100.70%5.49M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | --131.63 | -110.49%-453.92 | --0 | --0 | ---- | 550.39%4.33K | -144.72%-4.48K | 105.78%379.67 | 723.50%5.51K | -109.78%-960.63 |
| Net increase in cash and cash equivalents | 187.24%63.45M | 120.00%9M | 478.66%174.25M | -142.59%-99.69M | -154.48%-72.74M | 53.29%-45M | 39.84%-46.02M | 40.18%-41.09M | -266.21%-28.58M | 87.60%-96.35M |
| Add:Begin period cash and cash equivalents | 6.30%151.8M | -23.96%142.79M | -23.96%142.79M | -23.96%142.79M | -23.96%142.79M | -33.91%187.8M | -33.91%187.8M | -33.91%187.8M | -33.91%187.8M | -73.22%284.15M |
| End period cash equivalent | 207.25%215.25M | 6.30%151.8M | 123.62%317.04M | -70.62%43.11M | -56.00%70.06M | -23.96%142.79M | -31.73%141.78M | -31.91%146.7M | -42.39%159.21M | -33.91%187.8M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Unqualified opinion with explanatory notes | -- | -- | -- | Reservations with explanatory notes |
| Auditor | -- | Shenzhen Guangshen Certified Public Accountants (General Partnership) | -- | -- | -- | Shenzhen Guangshen Certified Public Accountants (General Partnership) | -- | -- | -- | Shenzhen Jiuan Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg